Skip to main content
Premium Trial:

Request an Annual Quote

Intrexon Goes Public, Shares Steeply Up on First Day of Trading

NEW YORK (GenomeWeb News) – Intrexon's shares were up as much as 69 percent on its first day of trading on the New York Stock Exchange today.

In afternoon trading, shares of the Germantown, Md.-based synthetic biology firm remained sharply up at 50 percent at $24.05.

It had priced its initial public offering of nearly 10 million shares at $16 per share, the upper end of an earlier anticipated price range. Intrexon also has granted underwriters a 30-day option to buy up to about 1.5 million additional shares of the company's stock. JP Morgan and Barclays are the joint book-running agents on the offering.

Intrexon's shares trade under ticker symbol "XON". The company filed to go public in early July.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.